The skin triggers’ therapy in the rehabilitation treatment of patients with fibromyalgia

Cover Page

Cite item

Full Text

Abstract

Materials and methods. 22 patients with fibromyalgia symptom complex were studied. The treatment proposed by the Protocol therapy skin triggers the back botulinum neurotoxin in very low doses.

The results of the study revealed a pronounced clinical efficacy of Botulinum neurotoxin A on the daily functioning of patients and their psycho-emotional status: normalization of sleep, reduced fatigue, a marked reduction in psychovegetative disorders and the absence of pain manifestations, as well as a decrease in the tendency to edema.

About the authors

Zhanna Yu. Yusova

Central State Medical Academy of the Administrative Department of the President of the Russian Federation

Author for correspondence.
Email: zyusova@mail.ru
SPIN-code: 7637-1663

DSc, Prof.

Russian Federation, Moscow

Larisa S. Kruglova

Central State Medical Academy of the Administrative Department of the President of the Russian Federation

Email: zyusova@mail.ru
SPIN-code: 1107-4372

DSc, Prof.

Russian Federation, Moscow

References

  1. Danilov AB. Fibromyalgia: diagnosis and the treatment (review). Polyclinic. 2016;4(3):18-23. (In Russ.).
  2. Esin RG, Esin OR, Lotfullina NZ, et al. Fibromyalgia is the syndrome of generalized pain without trigger zones: modern principles of diagnostics and treatment. Practical Medicine. 2015;5:83-87. (In Russ.).
  3. Epifanov VA, Epifanov AV, Kotenko KV, Korchazhkina NB. Reabilitacija pri zabolevanijah i povrezhdenijah nervnoj sistemy: Monografija [Rehabilitation for diseases and injuries of the nervous system: Monography]. Moscow: GEOTAR-Media; 2016. (In Russ.).
  4. Kotenko KV, Epifanov VA, Epifanov AV, Korchazhkina NB. Bol' v spine: diagnostika i lechenie: Monografija [Back pain: diagnosis and treatment: Monography]. Moscow: GEOTAR-Media; 2016. (In Russ.).
  5. Podchufarova ЕV. Anticonvulsive agents effectiveness and safety in the treatment of neuropathic pain syndromes and fibromyalgia. Russian Journal of Pain. 2014;2:25-29. (In Russ).
  6. Chichasova NV, Igolkina EV. Current therapy of fibromyalgia syndrome. Modern Rheumatology Journal. 2014;(2):76-82. (In Russ.). doi: 10.14412/1996-7012-2014-2-76-82. (In Russ).
  7. Tabeyeva GR. Fibromyalgia: development of symptoms and principles of therapy. Neurology, Neuropsychiatry, Psychosomatics. 2012;1:3-27. (In Russ).
  8. Topoljanskaja SV, Topoljanskij VD. Fibromyalgia. Medical Alphabet. 2014;6:18-23. (In Russ).
  9. Kopishinskaja SV. Gluten fibromyalgia. Nevrologicheskij zhurnal. 2015;20(3):48-53. (In Russ).
  10. Kolokolov OV, Sitkali IV, Shahpazov SZh, Kolokolova AM. Syndrome of chronic generalized pain ― a new interdisciplinary problem or competence of a general practitioner? Pharmateca. 2018;5:71-80. (In Russ).
  11. Kalyagin AN. Current diagnostic approaches for fibromyalgia. Modern Rheumatology Journal. 2012;6(1):11-14. doi: 10.14412/1996-7012-2012-708. (In Russ).
  12. Chichasova NV, Igolkina EV. Fibromyalgia syndrome: Can improvement be achieved? Modern Rheumatology Journal. 2012;6(2):16-24. (In Russ.) doi: 10.14412/1996-7012-2012-723. (In Russ).
  13. Wolf F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthr Care Res. 2010;62(5):600-17. doi: 10.1002/acr.20140.
  14. Rackley RR, Frenkl TL, Abdelmalak JB. Botulinum toxin: the promise of therapy for complex voiding dysfunction. Cont Urol. 2005;38-52.
  15. Proskurin VV. Refleksoterapiya boleznej nervnoj sistemy: Kratkoe rukovodstvo dlya vrachej [Reflexotherapy of the nervous system’s diseases: A quick guide for doctors]. Moscow; 1991. (In Russ).

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Marking of the lines of the back, areas with difficult rolling of the skin flap and pain points

Download (31KB)
3. Fig. 2. Integral indicator of the dermatological index of quality of life

Download (19KB)
4. Fig. 3. Average score on the adapted pain scale

Download (58KB)
5. Fig. 4. Results before and 1 month after treatment with botulinum neurotoxin A on the cutaneous trigger points of the back

Download (142KB)
6. Fig. 5. Results before and 1 month after treatment with botulinum neurotoxin A on the cutaneous trigger points of the back

Download (36KB)
7. Fig. 6. Results before and 1 month after treatment with botulinum neurotoxin A on the cutaneous trigger points of the back

Download (32KB)
8. Fig. 7. Results before and 1 month after treatment with botulinum neurotoxin A on the cutaneous trigger points of the back

Download (34KB)

Copyright (c) 2019 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies